Elevance Health, Inc. (ELV) stock
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3014% below fair value
$429.69−0.21 (-0.05%)
Close on Nov 13, 2026Market cap $92.84BP/E 18.3Yield –
Elevance Health gross margin
Gross margin is gross profit as a percentage of revenue.
Elevance Health's gross margin for the twelve months ending Sep 30, 2026 was 89.0%. For fiscal 2025 it was 89.4%, against 88.8% the year before. The highest annual figure on record is 100.0% in fiscal 2010.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 89.4% | +0.5 |
| FY2024 | Dec 31, 2024 | 88.8% | −1.1 |
| FY2023 | Dec 31, 2023 | 89.9% | −1.8 |
| FY2022 | Dec 31, 2022 | 91.7% | −0.5 |
| FY2021 | Dec 31, 2021 | 92.1% | −0.5 |
| FY2020 | Dec 31, 2020 | 92.7% | −5.4 |
| FY2019 | Dec 31, 2019 | 98.1% | −1.9 |
| FY2018 | Dec 31, 2018 | 100.0% | +0.0 |
| FY2017 | Dec 31, 2017 | 100.0% | +0.2 |
| FY2012 | Dec 31, 2012 | 99.8% | −0.2 |
| FY2011 | Dec 31, 2011 | 100.0% | +0.0 |
| FY2010 | Dec 31, 2010 | 100.0% | +0.6 |
| FY2009 | Dec 31, 2009 | 99.4% | +0.1 |
| FY2008 | Dec 31, 2008 | 99.2% | −0.1 |
| FY2007 | Dec 31, 2007 | 99.3% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 89.0% | −0.4 |
| Q2 FY2026 | Jun 30, 2026 | 89.1% | −0.2 |
| Q1 FY2026 | Mar 31, 2026 | 89.1% | −0.7 |
| Q4 FY2025 | Dec 31, 2025 | 88.9% | +2.1 |
| Q3 FY2025 | Sep 30, 2025 | 89.4% | +0.7 |
| Q2 FY2025 | Jun 30, 2025 | 89.4% | +0.3 |
| Q1 FY2025 | Mar 31, 2025 | 89.8% | −1.2 |
| Q4 FY2024 | Dec 31, 2024 | 86.8% | −1.9 |
| Q3 FY2024 | Sep 30, 2024 | 88.7% | −0.4 |
| Q2 FY2024 | Jun 30, 2024 | 89.0% | −1.1 |
| Q1 FY2024 | Mar 31, 2024 | 91.0% | −0.7 |
| Q4 FY2023 | Dec 31, 2023 | 88.7% | −2.2 |
| Q3 FY2023 | Sep 30, 2023 | 89.2% | −2.2 |
| Q2 FY2023 | Jun 30, 2023 | 90.1% | −2.0 |
| Q1 FY2023 | Mar 31, 2023 | 91.7% | −0.7 |
| Q4 FY2022 | Dec 31, 2022 | 90.9% | −0.7 |
| Q3 FY2022 | Sep 30, 2022 | 91.4% | −0.5 |
| Q2 FY2022 | Jun 30, 2022 | 92.1% | −0.2 |
| Q1 FY2022 | Mar 31, 2022 | 92.4% | −0.4 |
| Q4 FY2021 | Dec 31, 2021 | 91.6% | −0.5 |
| Q3 FY2021 | Sep 30, 2021 | 91.9% | −1.0 |
| Q2 FY2021 | Jun 30, 2021 | 92.3% | −0.1 |
| Q1 FY2021 | Mar 31, 2021 | 92.9% | −0.4 |
| Q4 FY2020 | Dec 31, 2020 | 92.1% | −3.7 |
| Q3 FY2020 | Sep 30, 2020 | 92.9% | −4.3 |
| Q2 FY2020 | Jun 30, 2020 | 92.4% | −7.2 |
| Q1 FY2020 | Mar 31, 2020 | 93.3% | −6.7 |
| Q4 FY2019 | Dec 31, 2019 | 95.8% | −4.2 |
| Q3 FY2019 | Sep 30, 2019 | 97.2% | −2.8 |
| Q2 FY2019 | Jun 30, 2019 | 99.6% | −0.4 |
| Q1 FY2019 | Mar 31, 2019 | 100.0% | – |
| Q4 FY2018 | Dec 31, 2018 | 100.0% | – |
| Q3 FY2018 | Sep 30, 2018 | 100.0% | – |
| Q2 FY2018 | Jun 30, 2018 | 100.0% | – |
See a number that looks wrong?